ANTHERA PHARMACEUTICALS

anthera-pharmaceuticals-logo

Anthera Pharmaceuticals, Inc., a development stage biopharmaceutical company, focuses on developing and commercializing therapeutics to treat diseases associated with inflammation, including cardiovascular and autoimmune diseases. Its primary product candidates include varespladib methyl (A-002), which has completed its Phase 2 clinical studies for the treatment of acute coronary syndrome; varespladib sodium (A-001) that is in a Phase 2 clinical study for the prevention of acute chest syndrome a... ssociated with sickle cell disease; and A-623, which has completed Phase 1 clinical studies for the treatment of B-cell mediated autoimmune diseases. The company has license agreements with Eli Lilly and Company, and Shionogi & Co., Ltd. to develop and commercialize secretory phospholipase A2 or sPLA2 inhibitors for the treatment of cardiovascular disease and other diseases; and Amgen Inc., to develop and commercialize A-623. Anthera Pharmaceuticals, Inc. was founded in 2004 and is headquartered in Hayward, California.

#SimilarOrganizations #People #Financial #Website #More

ANTHERA PHARMACEUTICALS

Social Links:

Industry:
Biotechnology Health Care Pharmaceutical

Founded:
2004-01-01

Address:
Hayward, California, United States

Country:
United States

Website Url:
http://www.anthera.com

Total Employee:
11+

Status:
Active

Contact:
510-856-5600

Email Addresses:
[email protected]

Total Funding:
101.5 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network


Similar Organizations

apellis-pharmaceuticals-logo

Apellis Pharmaceuticals

Apellis Pharmaceuticals focusesย on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.

arvinas-logo

Arvinas

Arvinas focuses on developing novel therapeutics to treat a variety of diseases including cancer, pro-inflammatory, and autoimmune.

idera-pharmaceuticals-logo

Idera Pharmaceuticals

Idera Pharmaceuticals is engaged in the discovery and development of novel synthetic DNA and RNA-based drug candidates.

innovus-pharmaceuticals-logo

Innovus Pharmaceuticals

Innovus Pharmaceuticals develops healthcare products for dermatology, autoimmune, respiratory, and sexual dysfunction diseases.

neurana-pharmaceuticals-logo

Neurana Pharmaceuticals

Neurana Pharmaceuticals is currently developing a novel treatment for acute muscle spasms.

reata-pharmaceuticals-logo

Reata Pharmaceuticals

Reata Pharmaceuticals is a biopharmaceutical company that develops drugs for cancer, inflammation, and neurodegenerative diseases.


Current Advisors List

brian-mueller_image

Brian Mueller Board Member @ Anthera Pharmaceuticals
Board_member

sandra-v-navarra_image

Sandra V. Navarra Scientific Advisory Board @ Anthera Pharmaceuticals
Advisor

not_available_image

Adrian Liew Scientific Advisory Board @ Anthera Pharmaceuticals
Advisor

not_available_image

Daniel Tak Mao Chan Scientific Advisory Board @ Anthera Pharmaceuticals
Advisor

not_available_image

Daniel J. Odenheimer Scientific Advisory Board @ Anthera Pharmaceuticals
Advisor

paul-f-truex_image

Paul F. Truex Board Chairman @ Anthera Pharmaceuticals
Board_member

not_available_image

Drew McManigle Board Member @ Anthera Pharmaceuticals
Board_member

not_available_image

Kenneth Kalunian Scientific Advisory Board @ Anthera Pharmaceuticals
Advisor

Current Employees Featured

not_available_image

Renee Martin
Renee Martin Vice President, Nonclinical and Translational Sciences @ Anthera Pharmaceuticals
Vice President, Nonclinical and Translational Sciences
2011-11-01

not_available_image

Colin Hislop
Colin Hislop Senior Vice President and Chief Medical Officer @ Anthera Pharmaceuticals
Senior Vice President and Chief Medical Officer

paul-f-truex_image

Paul F. Truex
Paul F. Truex President & CEO, Director @ Anthera Pharmaceuticals
President & CEO, Director
2004-01-01

not_available_image

Paula Adams
Paula Adams Vice President, Regulatory Affairs and Compliance @ Anthera Pharmaceuticals
Vice President, Regulatory Affairs and Compliance
2012-01-01

dave-thompson_image

Dave Thompson
Dave Thompson Director @ Anthera Pharmaceuticals
Director
2005-01-01

not_available_image

May Liu
May Liu Senior Vice President, Finance and Administration @ Anthera Pharmaceuticals
Senior Vice President, Finance and Administration

debra-odink_image

Debra Odink
Debra Odink Senior Vice President and Chief Technology Officer @ Anthera Pharmaceuticals
Senior Vice President and Chief Technology Officer
2011-12-01

not_available_image

Craig Thompson
Craig Thompson President & COO @ Anthera Pharmaceuticals
President & COO

chuck-olson_image

Chuck Olson
Chuck Olson CTO @ Anthera Pharmaceuticals
CTO

Founder


paul-f-truex_image

Paul F. Truex

Stock Details


Company's stock symbol is OTCPINK:ANTH

Investors List

herculescapital_image

Hercules Capital

Hercules Capital investment in Post-IPO Debt - Anthera Pharmaceuticals

orbimed-advisors_image

OrbiMed

OrbiMed investment in Post-IPO Equity - Anthera Pharmaceuticals

caxton-associates_image

Caxton Associates

Caxton Associates investment in Post-IPO Equity - Anthera Pharmaceuticals

mitsubishi-corporation-life-sciences-venture_image

Mitsubishi International Corporation (MIC)

Mitsubishi International Corporation (MIC) investment in Venture Round - Anthera Pharmaceuticals

hbm-healthcare-investments-ag_image

HBM Healthcare Investments AG

HBM Healthcare Investments AG investment in Venture Round - Anthera Pharmaceuticals

sofinnova-ventures_image

Sofinnova Investments

Sofinnova Investments investment in Venture Round - Anthera Pharmaceuticals

pappas-ventures_image

Pappas Ventures

Pappas Ventures investment in Venture Round - Anthera Pharmaceuticals

caxton-advantage-life-sciences-fund_image

Caxton Advantage Life Sciences Fund

Caxton Advantage Life Sciences Fund investment in Venture Round - Anthera Pharmaceuticals

vantagepoint-capital-partners_image

VantagePoint Capital Partners

VantagePoint Capital Partners investment in Venture Round - Anthera Pharmaceuticals

sofinnova-ventures_image

Sofinnova Investments

Sofinnova Investments investment in Venture Round - Anthera Pharmaceuticals

Official Site Inspections

http://www.anthera.com

  • Host name: h7.hostdl.com
  • IP address: 148.251.116.174
  • Location: Germany
  • Latitude: 51.2993
  • Longitude: 9.491
  • Timezone: Europe/Berlin

Loading ...

More informations about "Anthera Pharmaceuticals" on Search Engine